EX-12.1 2 a06-21552_1ex12d1.htm EX-12

Exhibit 12.1

United Therapeutics Corporation
Ratio of Earnings to Fixed Charges
(Unaudited)

 

 

 

Nine Months
Ended
September 30,

 

Years Ended December 31,

 

(in thousands, except ratio)

 

2006

 

2005

 

2004

 

2003

 

2002

 

2001

 

Earnings (losses) from continuing operations before fixed charges

 

 

$

25,433

 

 

$

42,893

 

$

13,209

 

$

(11,526

)

$

(18,003

)

$

(46,939

)

Fixed charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expenses, net of capitalized interest

 

 

$

1

 

 

$

29

 

$

3

 

$

112

 

$

117

 

$

173

 

Capitalized interest

 

 

—

 

 

—

 

—

 

—

 

—

 

—

 

Portion of rentals representative of interest factor

 

 

695

 

 

—

 

—

 

—

 

—

 

—

 

Total fixed charges

 

 

696

 

 

29

 

3

 

112

 

117

 

173

 

Ratio of earnings to fixed charges

 

 

36.54

 

 

1,479.07

 

4,403.00

 

—

 

—

 

—

 

Excess fixed charges over earnings

 

 

$

—

 

 

$

—

 

$

—

 

$

11,638

 

$

18,120

 

$

47,112

 

 

NOTE:  The Ratio of Earnings to Fixed Charges should be read in conjunction with the Consolidated Financial Statements and related Notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations in United Therapeutics Corporation’s Annual Report on Form 10-K for the year ended December 31, 2005 and Quarterly Report on Form 10-Q for the period ended September 30, 2006.